Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 820.50
+6.15 (0.76%)
At close: Aug 21, 2026
Alembic Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Alembic Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹949.30. The average 1-year stock price forecast is 15.70% higher than the current stock price, while the lowest is ₹800.00 (-2.50%) and the highest is ₹1,132 (+37.96%).
Price Target: ₹949.30 (+15.70%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alembic Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 11 | 11 | 10 | 10 | 10 |
Financial Forecast
Revenue This Year
84.17B
from 73.45B
Increased by 14.60%
Revenue Next Year
92.45B
from 84.17B
Increased by 9.84%
EPS This Year
36.99
from 37.62
Decreased by -1.69%
EPS Next Year
48.02
from 36.99
Increased by 29.83%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.